Gyeonggi-do, South Korea

Yeon-Jung Park



Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Ulsan, KR (2016)
  • Gyeonggi-do, KR (2019)

Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yeon-Jung Park: Innovator in Pharmaceutical Science

Introduction

Yeon-Jung Park is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative compounds for medical applications. With a total of two patents to his name, Park's work focuses on addressing critical health issues.

Latest Patents

Yeon-Jung Park's latest patents include the development of 4-aminopyrazolo[3,4-d]pyrimidinylazabicyclo derivatives and a pharmaceutical composition comprising the same. This invention relates to compounds that exhibit BTK inhibitory activity, which is crucial for the prevention and treatment of autoimmune diseases and cancers. His second patent involves a composition containing tauroursodeoxycholic acid, aimed at preventing or treating periodontal disease and improving oral hygiene.

Career Highlights

Park is currently associated with Daewoong Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to developing effective treatments that can significantly improve patient outcomes.

Collaborations

Some of Yeon-Jung Park's coworkers include Youn-Jung Yoon and Jung-eun Park, who collaborate with him in various research and development projects.

Conclusion

Yeon-Jung Park's contributions to pharmaceutical science through his innovative patents highlight his dedication to improving healthcare solutions. His work not only addresses pressing medical needs but also showcases the potential of scientific research in transforming lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…